Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Immunocellular Thera (IMUC)

0.335 -0.003 (-0.946%)

8/18/2017  3:59pm

Open:

0.357

Pre. Close:

0.338

High:

0.360

Low:

0.310

Volume:

1,670,496

Market Cap:

1.16M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.36 - 0.53

0.53 - 0.86

Low:

0.3 - 0.42

0.42 - 0.67

Close:

0.33 - 0.49

0.49 - 0.8

Technical analysis  (as of: 2017-08-18 4:41:51 PM)

Overall:

      

Stoxline posted a BUY today, downgraded from strong buy. But this stock still is very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 1.16     One year: 1.69

Support:

Support1: 0.25    Support2: 0.21

Resistance:

Resistance1: 0.99    Resistance2: 1.45

Pivot:

0.32

Moving Averages:

MA(5): 0.31     MA(20): 0.33

MA(100): 1.34     MA(250): 2.49

MACD:

MACD(12,26): -0.13     Signal(12,26,9): -0.16

%K %D:

%K(14,3): 57.13     %D(3): 44.55

RSI:

RSI(14): 39.84

52-Week:

High: 6.400  Low: 0.250  Change(%): -93.6

Average Vol(K):

3-Month: 98273  10-Days 34887

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
IMUC has closed below upper band by 36.1%. Bollinger Bands are 86.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to IMUC's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sat, 19 Aug 2017 06:22:30 GMT
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) Just Bounced; What's Next?

Mon, 14 Aug 2017 21:56:15 GMT
ImmunoCellular Therapeutics Announces Second Quarter 2017 Financial Results

Tue, 18 Jul 2017 14:15:00 GMT
Immunocellular prices equity offering; shares down 48%

Wed, 19 Jul 2017 14:15:00 GMT
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC): Here's Our Take

Thu, 29 Jun 2017 20:03:45 GMT
ImmunoCellular Therapeutics Receives Notice from NYSE MKT for Noncompliance ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

10.34

Shares Float (M)

3.46

% Held by Insiders

% Held by Institutions

Shares Short (K)

428

Shares Short Prior Month (K)

516

Stock Financials

EPS

-7.150

EPS Est. Current Year

-5.200

EPS Est. Next Year

-5.200

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

0.140

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-81.9

Return on Equity (ttm)

-262.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.222

Qtrly Earnings Growth

Operating Cash Flow (M)

-20.58

Levered Free Cash Flow (M)

-14.08

FoxReading.com

Valuation

P/E

-0.05

P/E Growth Ratio

-0.01

P/BV

2.39

P/S

P/CF

-0.17

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-11-21

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.